J
John T. Brooks
Researcher at Centers for Disease Control and Prevention
Publications - 257
Citations - 24952
John T. Brooks is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 71, co-authored 241 publications receiving 21084 citations. Previous affiliations of John T. Brooks include Emory University.
Papers
More filters
Journal ArticleDOI
The Association of HIV Susceptibility Testing With Survival Among HIV-Infected Patients Receiving Antiretroviral Therapy: A Cohort Study
Frank J. Palella,Carl Armon,Kate Buchacz,Stephen R. Cole,Joan S. Chmiel,Richard M. Novak,Kathleen C. Wood,Anne C. Moorman,John T. Brooks +8 more
TL;DR: It is found that, over a median follow-up of about 3 years, patients who had HIV-1 susceptibility testing were less likely to die than were patients who did not have testing, and the association was due to better antiretroviral treatment selection in tested patients or due to confounding.
Journal ArticleDOI
Disparities in the quality of HIV care when using US Department of Health and Human Services Indicators
Keri N. Althoff,Peter F Rebeiro,John T. Brooks,Kate Buchacz,Kelly A. Gebo,Jeffrey N. Martin,Robert Hogg,Jennifer E. Thorne,Marina B. Klein,M. John Gill,Timothy R. Sterling,Baligh R. Yehia,Michael J. Silverberg,Heidi M. Crane,Amy C. Justice,Stephen J. Gange,Richard D. Moore,Mari M. Kitahata,Michael A. Horberg,Gregory D. Kirk,Constance A. Benson,Ronald J. Bosch,Ann C. Collier,Stephen L. Boswell,Chris Grasso,Kenneth H. Mayer,Robert S. Hogg,Robert S. Hogg,P. Richard Harrigan,Julio S. G. Montaner,Angela Cescon,Hasina Samji,Kelly A. Gebo,Richard D. Moore,John T. Carey,James J. Goedert,Lisa P. Jacobson,Marina B. Klein,Marina B. Klein,Sean B. Rourke,Ann N. Burchell,Anita R. Rachlis,Robert F. Hunter-Mellado,Angel M. Mayor,Steven G. Deeks,Jeffrey N. Martin,Jeffrey N. Martin,Michael S. Saag,Michael J. Mugavero,James H. Willig,Joseph J. Eron,Sonia Napravnik,Heidi M. Crane,Heidi M. Crane,Robert Dubrow,David A. Fiellin,David W Haas,Sally Bebawy,Megan Turner,Kathryn Anastos,Rosemary G. McKaig,Aimee M. Freeman,Carol Lent,Stephen E. Van Rompaey,Liz Morton,Justin McReynolds,William B. Lober,Alison G. Abraham,Bryan Lau,Jinbing Zhang,Jerry Jing,Elizabeth T. Golub,Shari Modur,David B. Hanna,Cherise Wong,Adell Mendes +75 more
TL;DR: Among patients, 71% were retained in care, 82% were prescribed treatment, and 78% had HIV RNA ≤200 copies/mL; younger adults, women, blacks, and injection drug users had poorer outcomes.
Journal Article
Infant sleep position and sudden infant death syndrome (SIDS) in the United States: joint commentary from the American Academy of Pediatrics and selected agencies of the Federal Government.
TL;DR: It seems clear that SIDS rates do decrease significantly after public campaigns aimed at reducing the incidence of prone sleeping, and there have been no increases in disorders such as aspiration, acute life-threatening events, and vomiting after infant sleeping position has changed almost exclusively to non-prone in several countries.
Journal ArticleDOI
Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020
Lara Bull-Otterson,Elizabeth B. Gray,Daniel S. Budnitz,Heather Strosnider,Lyna Z. Schieber,Joseph G. Courtney,Macarena C. García,John T. Brooks,William R. Mac Kenzie,Adi V. Gundlapalli +9 more
TL;DR: Although dispensing trends are returning to prepandemic levels, continued adherence to current clinical guidelines for the indicated use of these medications will ensure their availability and benefit to patients for whom their use is indicated.
Journal ArticleDOI
Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy–Experienced Patients with HIV Infection in North America
Steven G. Deeks,Stephen J. Gange,Mari M. Kitahata,Michael S. Saag,Amy C. Justice,Robert S. Hogg,Joseph J. Eron,John T. Brooks,Sean B. Rourke,M. John Gill,Ronald J. Bosch,Constance A. Benson,Ann C. Collier,Jeffrey N. Martin,Marina B. Klein,Lisa P. Jacobson,Benigno Rodriguez,Timothy R. Sterling,Gregory D. Kirk,Sonia Napravnik,Anita Rachlis,Liviana Calzavara,Michael A. Horberg,Michael J. Silverberg,Kelly A. Gebo,Margot Kushel,James J. Goedert,Rosemary G. McKaig,Richard D. Moore +28 more
TL;DR: Although the rates of multiple regimen failure have decreased dramatically over the past decade, mortality rates for those who have experienced failure of at least 2 regimens have remained high, which emphasizes that these factors remain important targets for those in need of more-aggressive therapeutic interventions.